Phase 1 CIDP Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.

Neuromyelitis Optica Spectrum Disorder (NMOSD)Multiple Sclerosis (MS)Myasthenia Gravis (MG)+4 more

Tongji Hospital6 enrolled1 locationNCT07526493

Recruiting

Phase 1

IVIG vs SCIG in CIDP

Chronic Inflammatory Demyelinating PolyneuropathyCIDPImmunoglobulin Deficiency

Rutgers, The State University of New Jersey20 enrolled1 locationNCT05584631